Japanese Leisure Stock News

TSE:6471
TSE:6471Machinery

NSK (TSE:6471) Valuation Check After Recent Share Pullback And Restructuring Profit Targets

Event context and recent share performance NSK (TSE:6471) shares have come under pressure recently, with a 1 day return of 1.39% and a 6% decline over the past week, adding to a roughly 9.8% pullback over the past month. See our latest analysis for NSK. While the recent 30 day share price return of a 9.8% decline suggests fading short term momentum, the 90 day share price return of 21.86% and 1 year total shareholder return of 87.69% point to a much stronger longer term picture. If NSK’s...
TSE:8473
TSE:8473Capital Markets

A Look At SBI Holdings (TSE:8473) Valuation After Dividend Hike And ¥50b Share Buyback

Why SBI Holdings (TSE:8473) just moved its dividend goalposts SBI Holdings (TSE:8473) has raised its year end dividend forecast to ¥75 per share and highlighted a completed ¥50b share buyback, following a board decision tied to profits in its Financial Services Business. See our latest analysis for SBI Holdings. The updated dividend and completed ¥50b buyback come after a weaker run in the share price, with a 30 day share price return of 17.6% and a year to date return of 14.26%. This...
TSE:5844
TSE:5844Banks

Kyoto Financial Group (TSE:5844) Valuation After Earnings Upgrade Special Dividend And Expanded Buyback

Kyoto Financial Group Inc (TSE:5844) has drawn investor attention after sharply raising its earnings guidance, funded by large gains on equity sales, and pairing that move with a special dividend and expanded share buyback plan. See our latest analysis for Kyoto Financial GroupInc. The flurry of guidance upgrades, special dividend plans and the expanded buyback has coincided with strong recent momentum, with a 30 day share price return of 15.21% and a 1 year total shareholder return of...
TSE:4967
TSE:4967Personal Products

Assessing Kobayashi Pharmaceutical (TSE:4967) Valuation After Oasis Management’s Governance Challenge

Governance dispute focuses attention on Kobayashi Pharmaceutical Oasis Management’s public campaign against Kobayashi Pharmaceutical (TSE:4967) and its move to a Company with an Audit and Supervisory Committee has pushed the company’s governance structure and board oversight firmly into the spotlight for shareholders. See our latest analysis for Kobayashi Pharmaceutical. The governance dispute has arrived after a period where the 90 day share price return of 7.41% contrasts with a weaker 3...
TSE:7013
TSE:7013Machinery

Assessing IHI (TSE:7013) Valuation After Recent Share Price Pullback And Long Term Rerating

Why IHI (TSE:7013) is on investors’ radar today IHI (TSE:7013) has recently drawn attention after a period of mixed share performance, with a negative month but a strong past 3 months and 1 year total return. This has prompted fresh questions about how its current valuation lines up with fundamentals. See our latest analysis for IHI. At a share price of ¥3,734.0, IHI has recently seen a 10.02% 1 month share price decline, following a strong 27.42% 3 month share price return and a very large 5...
TSE:4528
TSE:4528Pharmaceuticals

Ono Pharmaceutical (TSE:4528) Deepens AI-Driven R&D With Congruence Deal – A Strategic Shift?

Earlier in March 2026, Ono Pharmaceutical Co., Ltd. and Congruence Therapeutics expanded their drug discovery collaboration to cover neurology and immunology, giving Ono exclusive worldwide option rights over any resulting small molecule candidates and tying Congruence’s economics to upfront, milestone and tiered royalty payments. This move extends Ono’s use of Congruence’s Revenir computational platform beyond oncology into areas of significant unmet medical need, potentially reshaping the...
TSE:2768
TSE:2768Trade Distributors

A Look At Sojitz (TSE:2768) Valuation After New Rare Earths Supply Initiatives

Sojitz (TSE:2768) has moved into focus after fresh rare earths news linked to Lynas Rare Earths and Japan Australia Rare Earths, as investors reassess the trading house’s role in Japan’s supply security. See our latest analysis for Sojitz. Against this backdrop, Sojitz’s ¥6,256 share price sits after a 1 day share price return of 0.9% and a 90 day share price return of 24.6%. The 1 year total shareholder return of 96.3% points to strong momentum as investors react to its rare earths...
TSE:3774
TSE:3774Telecom

Assessing Internet Initiative Japan (TSE:3774) Valuation After Launch Of New Internal Security Assessment Service

Internet Initiative Japan (TSE:3774) has introduced a new Internal Vulnerability Assessment service within its Safous Security Assessment offering, giving customers broader visibility into security risks across internal networks and distributed sites. See our latest analysis for Internet Initiative Japan. The new security service arrives as Internet Initiative Japan’s share price trades at ¥2,333.5, with a 7 day share price return of 3.55% and a 30 day share price return of 4.97%. This...
TSE:3626
TSE:3626IT

A Look At TIS (TSE:3626) Valuation After Announcing A Large Share Buyback Program

Why TIS Announced a Large Share Buyback TIS (TSE:3626) has set out a sizeable share repurchase program, planning to buy back up to 20,000,000 shares, or 8.76% of its outstanding stock, by the end of September 2026. The company has allocated ¥50,000 million to the program, with the aim of increasing shareholder returns and improving capital efficiency. Part of the repurchased shares will be retained as treasury stock, and any amount above 5% is scheduled for cancellation. See our latest...
TSE:6724
TSE:6724Tech

Seiko Epson (TSE:6724) Valuation Check After Recent Share Price Weakness

Setting the scene for Seiko Epson shares Seiko Epson (TSE:6724) has drawn investor attention after recent share price pressure, with the stock showing negative returns over the past month and past 3 months, prompting closer scrutiny of its current valuation. See our latest analysis for Seiko Epson. Zooming out, the recent 7 day and 1 month share price declines sit against a year to date share price return that is only slightly negative. The 1 year total shareholder return of a 17% decline...
TSE:8306
TSE:8306Banks

New MUFG Leaders May Steer Capital Priorities For Undervalued Shares

Mitsubishi UFJ Financial Group (TSE:8306) has announced significant leadership changes at the senior executive level. Takuya Tanaka has been appointed Senior Managing Corporate Executive with responsibilities linked to commercial banking and wealth management. Yoshiaki Ueno has been appointed Managing Corporate Executive with a focus on corporate planning and group level management. These appointments mark a reshuffling of top roles that could influence group wide priorities and capital...
TSE:3480
TSE:3480Real Estate

J.S.B.Co.Ltd (TSE:3480) Swing Back To Q1 Profit Tests Volatility Narrative

J.S.B.Co.Ltd (TSE:3480) opened Q1 2026 with revenue of ¥16.8b and basic EPS of ¥18.13, alongside trailing twelve month EPS of ¥285.67 on revenue of ¥77.6b. Over recent quarters the company has seen quarterly revenue move between ¥15.3b and ¥27.0b while basic EPS has ranged from a loss of ¥24.20 per share to a profit of ¥267.87 per share, giving investors a wide set of earnings outcomes to weigh against the current print. With trailing net profit margin at 7.8% compared with 7.3% a year...
TSE:7203
TSE:7203Auto

Evaluating Toyota Motor (TSE:7203) After Recent Share Price Weakness And Conflicting Value Signals

Recent Performance Snapshot Toyota Motor (TSE:7203) has been trading under pressure recently, with the share price down about 2.8% on the day, 4.1% over the past week, and 9.0% over the past month. Despite that softer near term performance, the stock shows a 3.4% gain over the past 3 months, with longer term total returns of 26.8% over 1 year, 106.4% over 3 years, and 124.8% over 5 years. See our latest analysis for Toyota Motor. The recent 1 month share price decline sits against a much...
TSE:2929
TSE:2929Biotechs

Pharma Foods International Q2 Profit Challenges Bearish Earnings Narratives

Pharma Foods International (TSE:2929) has just posted its Q2 2026 numbers, with revenue of ¥16.7 billion and basic EPS of ¥2.31, alongside net income of ¥67 million. Over the last six quarters, the company has seen quarterly revenue move between ¥14.6 billion and ¥18.4 billion. Basic EPS has swung from a loss of ¥65.50 to a gain of ¥51.59 before landing at the latest ¥2.31 print, which puts the spotlight firmly on how much of that top line is actually flowing through to shareholders. For...
TSE:6503
TSE:6503Electrical

A Look At Mitsubishi Electric (TSE:6503) Valuation After Mixed Short And Long Term Share Price Moves

Recent performance snapshot for Mitsubishi Electric Mitsubishi Electric (TSE:6503) has drawn attention after a mixed share price pattern, with a 6.3% decline over the past month contrasting with a 13.8% gain in the past 3 months. Over longer horizons, the stock shows a 94.3% total return over the past year, 2.8x over 3 years, and 2.5x over 5 years. This sets the backdrop for evaluating its current fundamentals. See our latest analysis for Mitsubishi Electric. While the 1 month share price...
TSE:3193
TSE:3193Hospitality

Eternal Hospitality GroupLtd (TSE:3193) EPS Slide To ¥25 Challenges Bullish Growth Narratives

Eternal Hospitality GroupLtd (TSE:3193) has posted its Q2 2026 numbers with revenue of ¥12.8 billion and basic EPS of ¥25.03, alongside net income of ¥288.78 million, giving investors a clear snapshot of mid year trading. The company has seen quarterly revenue move from ¥11.2 billion in Q2 2025 to ¥12.8 billion in Q2 2026, while basic EPS shifted from ¥28.28 to ¥25.03 over the same period, and investors will be weighing these trends against the latest margin picture and how efficiently those...
TSE:3159
TSE:3159Specialty Retail

Maruzen CHI Holdings (TSE:3159) Margin Compression To 1.8% Tests Bullish Narratives

Maruzen CHI HoldingsLtd (TSE:3159) has wrapped up FY 2026 with fourth quarter revenue of ¥43.3b and basic EPS of ¥2.47, rounding out a year where quarterly revenue ranged between ¥43.1b and ¥49.3b and EPS moved from ¥17.29 in Q1 to ¥2.47 in Q4. Across the latest trailing twelve months, revenue came in at ¥185.1b with basic EPS of ¥36.03, which may encourage investors to focus less on headline growth stories and more on how the business is converting that top line into earnings. With trailing...
TSE:4996
TSE:4996Chemicals

Kumiai Chemical Industry Q1 Margin Compression Challenges Bullish Earnings Growth Narrative

Kumiai Chemical Industry (TSE:4996) has opened fiscal 2026 with Q1 revenue of ¥46,707 million and basic EPS of ¥32.74, setting a fresh reference point after a volatile run of quarterly earnings. The company has seen revenue move from ¥43,381 million in Q1 2025 to ¥46,707 million in Q1 2026, while basic EPS shifted from ¥33.25 to ¥32.74 over the same periods. This gives investors a clean snapshot of the top and bottom line as they weigh how a thinner 2.5% trailing net margin and that prior...
TSE:7741
TSE:7741Medical Equipment

Assessing Whether HOYA (TSE:7741) Still Looks Expensive After Strong Multi Year Returns

Why HOYA is on investors’ radar today HOYA (TSE:7741) has attracted attention after recent share price moves, with the stock up over the past 3 years and 5 years while posting mixed returns over the past week and month. See our latest analysis for HOYA. At a share price of ¥27,765, HOYA’s recent 7 day and 30 day share price returns of 2.61% and 2.44% declines contrast with a stronger 90 day share price return of 16.2% and a 1 year total shareholder return of 61.74%. This suggests longer term...
TSE:9697
TSE:9697Entertainment

Did Capcom’s (TSE:9697) Resident Evil PC Tie-in and Leadership Shuffle Just Reframe Its IP Strategy?

GIGABYTE recently announced a collaboration with Capcom to promote the upcoming Resident Evil Requiem game through a themed custom PC giveaway and bundled monitor-game offers, while Capcom’s board approved director changes and new management roles effective April 1, 2026. Together, the gaming hardware tie-in and leadership reshuffle highlight how Capcom is leaning on flagship IP while refining its internal business focus. We’ll now examine how the Resident Evil Requiem collaboration with...
TSE:9984
TSE:9984Wireless Telecom

Reassessing SoftBank Group (TSE:9984) After Recent Share Price Slide And AI Narrative Shifts

Wondering whether SoftBank Group's current share price actually lines up with its underlying value? This article walks through the numbers so you can see how the market is pricing the story. The stock closed at ¥3,578 after an 8.9% decline over the last 7 days, a 24.0% drop over 30 days and a 22.5% fall year to date, while the 1 year return sits at 83.4% and the 3 year return is very large at about 3x. These swings have come as SoftBank Group continues to be closely watched as a major...
TSE:6702
TSE:6702IT

Fujitsu’s AI Infrastructure Alliance With Arrcus and 1Finity Could Be A Game Changer For Fujitsu (TSE:6702)

In early March 2026, Arrcus announced a collaboration with Fujitsu and 1Finity to combine FUJITSU-MONAKA Arm-based CPUs, ArcOS software-defined networking, and high-speed optical interconnects into a secure, energy-efficient infrastructure for distributed AI workloads from edge inference to large-scale training. This partnership highlights Fujitsu’s push to align compute, networking, and optical transport for emerging Physical and enterprise AI use cases such as smart factories, robotics,...
TSE:8002
TSE:8002Trade Distributors

Assessing Marubeni’s Valuation As The Branford Castle Partnership Expands Global Investment Reach

Why Marubeni’s Branford Castle deal matters for shareholders Marubeni (TSE:8002) has drawn investor attention after committing capital to Branford Castle Partners’ new flagship fund and agreeing to work alongside the firm to source and support global investment opportunities. See our latest analysis for Marubeni. The Branford Castle agreement lands while Marubeni’s share price sits at ¥5,591, with a 1 day share price return of 4.02% and 7 day return of 3.86%. However, the 30 day share price...
TSE:6645
TSE:6645Electronic

Omron’s SF2030 Plan Targets Data Growth In Automation And Healthcare

OMRON (TSE:6645) has released its SF2030 2nd Stage medium term plan, outlining a broad shift toward data driven operations. The plan highlights increased focus on industrial automation, healthcare, and targeted growth in Europe. This roadmap sets out multi year priorities for redirecting investment and reshaping the company’s business mix. OMRON, trading at ¥4,532.0, enters this new phase after a mixed share price record, with a 13.4% return year to date and a 3.5% return over 1 year,...